Global Equine Pharmaceuticals & Supplements Market by Product (Pharmaceutical, Supplement), Distribution Channel (Drug Stores, Veterinary Hospitals)

The Equine Pharmaceuticals & Supplements Market size was estimated at USD 930.52 million in 2023, USD 983.49 million in 2024, and is expected to grow at a CAGR of 5.78% to reach USD 1,379.52 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Equine Pharmaceuticals & Supplements Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Equine Pharmaceuticals & Supplements Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Equine Pharmaceuticals & Supplements Market, highlighting leading vendors and their innovative profiles. These include Alltech, Bayer AG, Boehringer Ingelheim International GmbH, Cargill, Incorporated, Ceva Sante Animale, Dechra Veterinary Products Limited, Elanco Animal Health Incorporated, Equineproducts-uk Ltd., Lallemand, Inc., Merck & Co., Inc., Purina Animal Nutrition LLC, Thermo Fisher Scientific Inc., Vetoquinol USA, Virbac, and Zoetis Inc.

Market Segmentation & Coverage

This research report categorizes the Equine Pharmaceuticals & Supplements Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Pharmaceutical
  - Anti-Inflammatory
  - Anti-Ulcer Drugs
  - Sedative & Tranquilizer
- Supplement
  - Joint Supplements
  - Vitamins & Minerals
Distribution Channel
- Drug Stores
- Veterinary Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Equine Pharmaceuticals & Supplements Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Equine Pharmaceuticals & Supplements Market?
What are the technology trends and regulatory frameworks in the Equine Pharmaceuticals & Supplements Market?
What is the market share of the leading vendors in the Equine Pharmaceuticals & Supplements Market?
Which modes and strategic moves are suitable for entering the Equine Pharmaceuticals & Supplements Market?

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Equine Pharmaceuticals & Supplements Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing awareness about equine pharmaceuticals and supplements products
5.1.1.2. Rising demand for herbal feed, digestive, and energy supplements owing to the choice among horse breeders for organic products
5.1.1.3. Growing adoption of equine supplements in horse racing and equestrian sectors
5.1.2. Restraints
5.1.2.1. Stringent regulations regarding the pharmaceutical products and supplements
5.1.3. Opportunities
5.1.3.1. Growing emphasis on overall equine health and wellness, and extensively use of electrolyte supplements
5.1.3.2. Development of new equine pharmaceuticals & supplements
5.1.4. Challenges
5.1.4.1. Side effects on the health of equine
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Equine Pharmaceuticals & Supplements Market, by Product

6.1. Introduction
6.2. Pharmaceutical
6.3.1. Anti-Inflammatory
6.3.2. Anti-Ulcer Drugs
6.3.3. Sedative & Tranquilizer
6.3. Supplement
6.4.1. Joint Supplements
6.4.2. Vitamins & Minerals

7. Equine Pharmaceuticals & Supplements Market, by Distribution Channel

7.1. Introduction
7.2. Drug Stores
7.3. Veterinary Hospitals

8. Americas Equine Pharmaceuticals & Supplements Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Equine Pharmaceuticals & Supplements Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Equine Pharmaceuticals & Supplements Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
12.1.1. Alltech
12.1.2. Bayer AG
12.1.3. Boehringer Ingelheim International GmbH
12.1.4. Cargill, Incorporated
12.1.5. Ceva Sante Animale
12.1.6. Dechra Veterinary Products Limited
12.1.7. Elanco Animal Health Incorporated
12.1.8. Equineproducts-uk Ltd.
12.1.9. Lallemand, Inc.
12.1.10. Merck & Co., Inc.
12.1.11. Purina Animal Nutrition LLC
12.1.12. Thermo Fisher Scientific Inc.
12.1.13. Vetoquinol USA
12.1.14. Virbac
12.1.15. Zoetis Inc.
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET RESEARCH PROCESS
FIGURE 2. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2023 VS 2030
FIGURE 3. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET DYNAMICS
FIGURE 7. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 10. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 8. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-ULCER DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SEDATIVE & TRANQUILIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 13. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY JOINT SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 16. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 33. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 34. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 37. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 38. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. CHINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. CHINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 55. CHINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 56. CHINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. INDIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. INDIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 59. INDIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 60. INDIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. INDONESIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. JAPAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. JAPAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 67. JAPAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 68. JAPAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. MALAYSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. PHILIPPINES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. SINGAPORE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. SOUTH KOREA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. TAIWAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. THAILAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. THAILAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 91. THAILAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 92. THAILAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. VIETNAM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. VIETNAM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 102. DENMARK EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. DENMARK EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 104. DENMARK EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 105. DENMARK EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. EGYPT EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. EGYPT EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 108. EGYPT EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 109. EGYPT EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. FINLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. FINLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 112. FINLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 113. FINLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. FRANCE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. FRANCE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 116. FRANCE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 117. FRANCE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 120. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 121. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. ISRAEL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. ITALY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. ITALY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 128. ITALY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 129. ITALY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. NETHERLANDS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. NETHERLANDS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. NORWAY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. NORWAY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 140. NORWAY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 141. NORWAY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. POLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. POLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 144. POLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 145. POLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. QATAR EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. QATAR EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 148. QATAR EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 149. QATAR EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. SPAIN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. SPAIN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 164. SPAIN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 165. SPAIN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. SWEDEN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. SWITZERLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. TURKEY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. TURKEY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 176. TURKEY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 177. TURKEY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 187. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 188. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Alltech
Bayer AG
Boehringer Ingelheim International GmbH
Cargill, Incorporated
Ceva Sante Animale
Dechra Veterinary Products Limited
Elanco Animal Health Incorporated
Equineproducts-uk Ltd.
Lallemand, Inc.
Merck & Co., Inc.
Purina Animal Nutrition LLC
Thermo Fisher Scientific Inc.
Vetoquinol USA
Virbac
Zoetis Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	182
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 983.49 Million
Forecasted Market Value ( USD ) by 2030	$ 1379.52 Million
Compound Annual Growth Rate	5.7%
Regions Covered	Global

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3712EUR$3,939USD£3,107GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€4664EUR$4,949USD£3,904GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6568EUR$6,969USD£5,497GBP

Global Equine Pharmaceuticals & Supplements Market by Product (Pharmaceutical, Supplement), Distribution Channel (Drug Stores, Veterinary Hospitals) - Forecast 2024-2030

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned (Partial List)

Methodology

Table Information

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned (Partial List)

Methodology

Table Information

Related Topics

Related Reports

Equine Pharmaceuticals & Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

Global Equine Operating Table Market by Type (Fixed Equine Operating Tables, Hydraulic Equine Operating Tables, Mobile Equine Operating Tables), End-User (Specialized Equine Hospitals, Veterinary Hospitals & Clinics) - Forecast 2024-2030

Global Udder Health Market Size, Share & Trends by Product (Pharmaceuticals (Antibiotics, Intramammary Infusions), Devices (Milk Quality Analysers), Supplements)), Veterinary Care Settings (Dairy Farms, Veterinary Hospitals & Clinics), Animal Type - Forecast to 2029

Veterinary Hospital Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F

Global Swine Lameness Diagnostic Market Size, Share & Trends Analysis Report by Sector (Public, Private), Service Provider (Veterinary Hospital/Clinic Laboratories), Region, and Segment Forecasts, 2024-2030